Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial
- PMID: 16827823
- DOI: 10.1111/j.1471-0528.2006.00998.x
Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the MIST trial
Abstract
Objectives: To compare the cost-effectiveness of alternative management methods of first-trimester miscarriage.
Design: Economic evaluation conducted alongside a large randomised controlled trial (the MIST trial).
Setting: Early pregnancy assessment units of seven participating hospitals in southern England.
Sample: A total of 1200 women with a confirmed pregnancy of less than 13 weeks of gestation with a diagnosis of incomplete miscarriage or missed miscarriage.
Methods: Random allocation to expectant management, medical management or surgical management. Collection of health service and broader resource use data, unit costs for each resource item and clinical outcomes.
Main outcome measures: Costs (pounds, 2001-02 prices) to the health service, social services, women, carers and wider society during the first 8 weeks postrandomisation. Cost-effectiveness estimates, expressed in terms of incremental cost per gynaecological infection prevented; cost-effectiveness acceptability curves presented at alternative willingness-to-pay thresholds for preventing gynaecological infection.
Results: There was no significant difference in the incidence of gynaecological infection between groups. The net societal cost per woman was estimated at 1086.20 pounds in the expectant group, 1410.40 pounds in the medical group and 1585.30 pounds in the surgical group. Expectant management had a 97.8% probability of being the most cost-effective management method at a willingness-to-pay threshold of 10,000 pounds for preventing one gynaecological infection, while medical management had a 2.2% probability of being the most cost-effective management method. Expectant management retained the highest probability of being the most cost-effective management method at all willingness-to-pay thresholds of less than 70,000 pounds for preventing one gynaecological infection.
Conclusions: Expectant and medical management of first-trimester miscarriage possess significant economic advantages over traditional surgical management.
Comment in
-
Economic evaluation of alternative management methods of first-trimester miscarriage based on results from the miscarriage treatment (MIST) trial by Petrou et al.BJOG. 2007 Jan;114(1):116-7. doi: 10.1111/j.1471-0528.2006.01164.x. BJOG. 2007. PMID: 17233871 No abstract available.
Similar articles
-
Women's preferences for attributes of first-trimester miscarriage management: a stated preference discrete-choice experiment.Value Health. 2009 Jun;12(4):551-9. doi: 10.1111/j.1524-4733.2008.00459.x. Epub 2008 Sep 16. Value Health. 2009. PMID: 18798807
-
Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial).BMJ. 2006 May 27;332(7552):1235-40. doi: 10.1136/bmj.38828.593125.55. Epub 2006 May 17. BMJ. 2006. PMID: 16707509 Free PMC article. Clinical Trial.
-
Cost-effectiveness of curettage vs. expectant management in women with an incomplete evacuation after misoprostol treatment for first-trimester miscarriage: a randomized controlled trial and cohort study.Acta Obstet Gynecol Scand. 2018 Mar;97(3):294-300. doi: 10.1111/aogs.13283. Epub 2018 Jan 19. Acta Obstet Gynecol Scand. 2018. PMID: 29266169 Clinical Trial.
-
Which approach for first trimester miscarriage?Drug Ther Bull. 2009 Jul;47(7):77-80. doi: 10.1136/dtb.2009.06.0025. Drug Ther Bull. 2009. PMID: 19567842 Review.
-
Expectant management of first-trimester miscarriage.J Obstet Gynaecol. 2009 Nov;29(8):681-5. doi: 10.3109/01443610903215399. J Obstet Gynaecol. 2009. PMID: 19821656 Review.
Cited by
-
The cost-effectiveness of progesterone in preventing miscarriages in women with early pregnancy bleeding: an economic evaluation based on the PRISM trial.BJOG. 2020 May;127(6):757-767. doi: 10.1111/1471-0528.16068. Epub 2020 Jan 30. BJOG. 2020. PMID: 32003141 Free PMC article.
-
Progesterone to prevent miscarriage in women with early pregnancy bleeding: the PRISM RCT.Health Technol Assess. 2020 Jun;24(33):1-70. doi: 10.3310/hta24330. Health Technol Assess. 2020. PMID: 32609084 Free PMC article. Clinical Trial.
-
Medical treatments for incomplete miscarriage (less than 24 weeks).Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007223. doi: 10.1002/14651858.CD007223.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2013 Mar 28;(3):CD007223. doi: 10.1002/14651858.CD007223.pub3. PMID: 20091626 Free PMC article. Updated.
-
Misoprostol for medical treatment of missed abortion: a systematic review and network meta-analysis.Sci Rep. 2017 May 10;7(1):1664. doi: 10.1038/s41598-017-01892-0. Sci Rep. 2017. PMID: 28490770 Free PMC article.
-
Medical treatment for early fetal death (less than 24 weeks).Cochrane Database Syst Rev. 2019 Jun 17;6(6):CD002253. doi: 10.1002/14651858.CD002253.pub4. Cochrane Database Syst Rev. 2019. PMID: 31206170 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical